AVANIR PHARMACEUTICALS Aktie

2,19 EUR 0,2290%

Zu Ihrem Onlinebroker

kaufen verkaufen

AVANIR PHARMACEUTICALS Aktienkurs : 24.05. ( 15 Min. verzögert)
2,19 € Letzter Kurs	0,23% Veränderung	2,18 € Vortag	2,19 € Eröffnungskurs

Realtime:

2,19

0,23%

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
2,24 - 2,19 Tag	0,0000000 - 0,0000000 52 Wochen	0 Tag	54 Ø 52 Wochen	0,0000000 0 Stücke	0,0000000 0 Stücke

AVANIR PHARMACEUTICALS Aktien…

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

24.05.

Brinson Patrick Reports Record $90 Million Raised by US Life Sciences ...

... the first quarter included Threshold Pharmaceuticals Inc., South San Francisco, Calif; Cerus Corp., Concord, Calif.; Celldex Therapeutics Inc., Needham, Mass.; and Avanir Pharmaceuticals ...
17.05.

Avanir Pharmaceuticals CEO Presents at Bank of America Merrill Lynch Health ...

... 1:00 PM ET (inaudible) one of the biotech analysts here at Bank of America Merrill Lynch. It's my pleasure to introduce Avanir Pharmaceuticals who's ...

10.05.

Canaccord Genuity Reaffirms Buy Rating on Avanir Pharmaceuticals (AVNR)

Avanir Pharmaceuticals (NASDAQ: AVNR)'s stock had its “buy” rating reaffirmed by research analysts at Canaccord Genuity in a report released on Wednesday. Avanir Pharmaceuticals opened at 2.76 on Wednesday. Avanir Pharmaceuticals has a 1-year low of ...
09.05.

Avanir Pharmaceuticals Catches Analysts Sleeping Again

By Seth Jayson, The Motley Fool Avanir Pharmaceuticals (NAS: AVNR) reported earnings on May 8. Here are the numbers you need to know. For the quarter ended March...
08.05.

Avanir Pharmaceuticals Reports Fiscal 2012 Second Quarter Financial and ...

ALISO VIEJO, Calif., May 8, 2012 /PRNewswire via COMTEX/ -- Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR) today reported financial results for the three and six months ended March 31, 2012. "We are pleased with...